R935788 tablets

R935788 · Rigel Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R935788 tablets, covering 2016-07-15 to 2016-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) [Phase 2]